Satraplatin
Based on 1 publication(s) in Google Scholar
Satraplatin is an alkylating agent, with potent antitumor effect.
For research use only. We do not sell to patients.
- Purity : 99.79%
- CAS No.: 129580-63-8
- Formula: C10H22Cl2N2O4Pt
- Molecular Weight:500.28
-
Storage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
-
Solvent & Solubility
- Purity & Documentation
- References
-
Help & FAQs
-
HY-B0077
Bendamustine hydrochlorideDNA Cross-linking Agent -
HY-13585
CarmustineDNA/RNA Alkylator -
HY-14798
Palifosfamide -
HY-B0181
AltretamineDNA Alkylator/Crosslinker -
HY-B0245
BusulfanAlkylating Antineoplastic Agent -
HY-13669
LomustineDNA Alkylator -
HY-16503
TreosulfanAlkylating Cytotoxic Agent -
HY-17394
CisplatinDNA Alkylator -
HY-17364
TemozolomideDNA Alkylator -
HY-17420
CyclophosphamideAlkylating Agent -
HY-17574
Thio-TEPABacterial Inhibitor -
HY-13733
Procarbazine HydrochlorideAlkylating Agent
Publications Citing Use of MedChemExpress (MCE) Satraplatin
More
Biological Activity
Description
In Vitro
Satraplatin needs to avoid light in the solution, and it is unstable in the alkaline state but stable in the acidic state.Satraplatin has potent antitumor activity. Satraplatin combined with dichloroacetate (DCA) inhibits UMC-11 cells with an IC50 of 1.36 ± 0.11 μM[1]. Satraplatin also suppresses CDDP-resistant (KB-R) cells (IC50, 7.04 μM), and causes G2/M arrest in KB-R cells[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. .
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Chemical Information
-
CAS No. 129580-63-8
-
Appearance Solid
-
Molecular Weight 500.28
-
Formula C10H22Cl2N2O4Pt
-
Color Off-white to yellow
-
SMILES
[Cl-][Pt+4]([O-]C(C)=O)([O-]C(C)=O)([Cl-])([NH3])[NH2]C1CCCCC1
-
Synonyms
BMS182751; BMY45594; JM216
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years 4°C 2 years In solvent -80°C 2 years -20°C 1 year
Publications (1)
-
Journal Impact Factor
-
Most Recent
Solvent & Solubility
In Vitro:
DMF : 10 mg/mL (19.99 mM; ultrasonic and adjust pH to 1 with HCl; DMSO can inactivate Satraplatin's activity)
Ethanol : < 1 mg/mL (insoluble; DMSO can inactivate Satraplatin's activity)
H2O : < 0.1 mg/mL (insoluble; DMSO can inactivate Satraplatin's activity)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Purity & Documentation
-
Data Sheet (277 KB)
-
SDS (396 KB)
- English - EN (396 KB)
- Français - FR (396 KB)
- Deutsch - DE (396 KB)
- Norwegian - NO (396 KB)
- Español - ES (396 KB)
- Swedish - SV (396 KB)
- Italian - IT (396 KB)
- Korean - KR (396 KB)
- Portuguese - PT (396 KB)
-
Handling Instructions (2659 KB)
References
[1]. Fiebiger W, et al. In vitro cytotoxicity of novel platinum-based drugs and dichloroacetate against lung carcinoid cell lines. Clin Transl Oncol. 2011 Jan;13(1):43-9. [Content Brief]
[2]. Yamano Y, et al. Antitumor activity of satraplatin in cisplatin-resistant oral squamous cell carcinoma cells. Head Neck. 2011 Mar;33(3):309-17. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMF | 1 mM | 1.9989 mL | 9.9944 mL | 19.9888 mL | 49.9720 mL |
| 5 mM | 0.3998 mL | 1.9989 mL | 3.9978 mL | 9.9944 mL | |
| 10 mM | 0.1999 mL | 0.9994 mL | 1.9989 mL | 4.9972 mL | |
| 15 mM | 0.1333 mL | 0.6663 mL | 1.3326 mL | 3.3315 mL |
Satraplatin Related Classifications
HY-17576 Related Classifications
Powered by Bioz